Clinical Immunogenicity Considerations for Biosimilar and Interchangeable Insulin Products

Guidance for Industry - Biosimilars
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news